Clinical development of products for specific immunotherapy for the treatment of allergic diseases - Scientific guideline

Scientific guidelineHumanScientific guidelines

Icelandic is available via eTranslation, the European Commission's machine translation service.

Translate to Icelandic | Important information about machine translation

This document provides guidance for the development of studies of products for specific immunotherapy to enhance the assessment and comparison of results of such studies.

Keywords: Allergic disease, specific immunotherapy, allergic rhinoconjunctivitis

Current effective version

Guideline on the clinical development of products for specific immunotherapy for the treatment of allergic diseases

Adopted Reference Number: CHMP/EWP/18504/2006 Legal effective date:

English (EN) (169.46 KB - PDF)

Fyrst birt: Síðast uppfært:
Skoða

Document history - First version (current)

Guideline on the clinical development of products for specific immunotherapy for the treatment of allergic diseases

Adopted Reference Number: CHMP/EWP/18504/2006 Legal effective date:

English (EN) (169.46 KB - PDF)

Fyrst birt: Síðast uppfært:
Skoða

Draft guideline on the clinical development of products for specific immunotherapy for the treatment of allergic diseases

Draft: consultation closed Reference Number: CHMP/EWP/18504/2006

English (EN) (78.49 KB - PDF)

Fyrst birt: Síðast uppfært:
Skoða

Concept paper on the preparation of a guideline on the clinical development of products for specific immunotherapy for the treatment of allergic diseases

Reference Number: EMEA/CHMP/EWP/18504/2006

English (EN) (41.05 KB - PDF)

Fyrst birt: Síðast uppfært:
Skoða

Share this page